Table 2.

Outcome measures and safety endpoints.

Outcome measures and safety endpoints	N = 30
First pass effect – n. (%)	7 (24%)
Number of passes – median (IQR)	1 (1–2)
Good reperfusion rate eTICI2b-3 – n. (%)	28 (94%)
eTICI 3 – n. (%)	13 (48%)
Good functional outcome (mRS ≤2) – n. (%)	25 (83%)
Clinical outcome (mRS) at follow-up – median (IQR)	1 (1–2)
NIHSS 24-hours post-procedural – n. (%)	2 (1–6)
Symptomatic intracranial hemorrhage – n. (%)	1 (3%)a
Asymptomatic intracranial hemorrhage – n. (%)	2 (6%)
Vasospasm – n. (%)	0
Vessel Dissection – n. (%)	0
Vessel Perforation – n. (%)	0
Distal embolic vessel occlusion – n. (%)	0
New ischemic event within 24-hours – n. (%)	0
Re-occlusion within 24-hours – n. (%)	1 (3%)
Mortality rate within 24-hours post-procedural – n. (%)	0
Mortality rate with the follow-up period – n. (%)	3 (10%)b
Other severe adverse events – n. (%)	1 (3%)b

eTICI, extended Thrombolysis in Cerebral Infarction scale; IQR, interquartile range; mRS, modified Ranking Scale; n., number; NIHSS, National Institute of Health Stroke Scale.

^asICH occurred after bail-out maneuver with an additional device.

^bNot device related.